Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Potential of Nanoparticle-Based Phototherapies for Future Treatment of Uveal Melanoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 14, 2026
Real-World, Evidence-Based, Retrospective Study of Patients Infused with Commercially Released Lifileucel for Advanced Melanoma.
Journal: Transplantation and cellular therapy
Published: February 05, 2026
Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancer.
Journal: Journal for immunotherapy of cancer
Published: November 23, 2025
A Review of Neoadjuvant PD-1 Inhibitors in the Setting of Cutaneous Malignancies.
Journal: The Journal of clinical and aesthetic dermatology
Published: June 20, 2025
Phase 1 first-in-human dose-escalation study of IMSA101, a novel cyclic di-nucleotide STING agonist, for patients with advanced solid tumor malignancies.
Journal: Journal for immunotherapy of cancer
Published: May 29, 2025
Comprehensive Profiling of Acral Lentiginous Melanoma Reveals Downregulated Immune Activation Compared to Cutaneous Melanoma.
Journal: Pigment cell & melanoma research
Published: April 27, 2025
Vedolizumab Dose Escalation Resolves Immune Checkpoint Inhibitor-Induced Colitis in Two Patients.
Journal: Case reports in oncological medicine
Published: April 07, 2025
Radiomics to predict high risk features in intraocular retinoblastoma.
Journal: Eye (London, England)
Published: February 25, 2025
Immune Profiling of Uveal Melanoma Liver Metastases and Response to Checkpoint Inhibitors.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: December 02, 2024
Last Updated: 09/26/2026